Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: Clozapine is the only antipsychotic approved for treatment-resistant schizophrenia, and clinicians should confidently be able to recognize and manage potential side effects of the medication, including myocarditis. Clozapine-induced myocarditis was reported in 1999 in a series of 15 cases (out of 8,000 patients prescribed clozapine: 0.19%), all within 3 weeks of starting clozapine. Five of these 15 patients died of clozapine-induced myocarditis.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.